Clinical Trials Logo

Filter by:
NCT ID: NCT00304668 Withdrawn - HIV Infections Clinical Trials

A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South Africa

Start date: n/a
Phase: Phase 1/Phase 2
Study type: Interventional

Approximately 42 HIV-negative women, aged >18 and < 50, will be enrolled in this study. Each volunteer will have a 2:1 chance of receiving Dapivirine Gel-002 versus placebo. The volunteers will receive investigational product for a total of 42 days.

NCT ID: NCT00306826 Withdrawn - Clinical trials for Glucose Metabolism Disorders

Pioglitazone in Impaired Glucose Tolerance

Start date: n/a
Phase: Phase 4
Study type: Interventional

In patients with impaired glucose tolerance (IGT), the researchers want to study the relative effects of pioglitazone, simvastatin, or the combination of both on: - intima media thickness (IMT) as an easily assessed marker of atherosclerosis - heart rate variability (HRV) as a marker of autonomic neuropathy - flow-mediated vasodilatation (FMD) of the brachial artery as a marker of endothelial function - vascular and metabolic lab parameters

NCT ID: NCT00309231 Withdrawn - Type 1 Diabetes Clinical Trials

Clinical Islet Transplantation Using the Edmonton Protocol

Start date: n/a
Phase: N/A
Study type: Observational

The purpose of this study is to perform a series of islet transplants using the Edmonton protocol. Patients with Type I Diabetes and glycemic lability, severe hypoglycemia or hypoglycemic unawareness will undergo transplantation of purified pancreatic islets from cadaveric donors into the portal vein, followed by steroid-free immunosuppression as per the Edmonton protocol (IL-2 antibody induction, sirolimus, low dose tacrolimus-based immunosuppression). The goals of the transplant are to improve glycemic control, stabilize blood sugars and achieve insulin independence.

NCT ID: NCT00311545 Withdrawn - Kidney Cancer Clinical Trials

S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer

Start date: n/a
Phase: Phase 2
Study type: Interventional

RATIONALE: Monoclonal antibodies, such as CNTO 328, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. PURPOSE: This phase II trial is studying how well CNTO 328 works in treating patients with unresectable or metastatic kidney cancer.

NCT ID: NCT00313976 Withdrawn - Multiple Sclerosis Clinical Trials

Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)

Start date: n/a
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate if the higher dose can give greater efficacy without negative impact on the adverse event profile for patients with early secondary progressive Multiple Sclerosis (SPMS).

NCT ID: NCT00324142 Withdrawn - Clinical trials for Recurrent Bacterial Vaginosis

A Pilot Study of Oral Tinidazole for Women With Recurrent Bacterial Vaginosis

Start date: n/a
Phase: Phase 2
Study type: Interventional

This is a study of the drug tinidazole for women with recurrent bacterial vaginosis. Half of the participants will get the drug for 10 days, the other half will get the drug for 10 days and then twice a week for 12 weeks.

NCT ID: NCT00329316 Withdrawn - Pregnancy Clinical Trials

Prevention of Recurrent Preterm Delivery by a Natural Progesterone Agent

Start date: n/a
Phase: N/A
Study type: Interventional

To examine the preterm delivery rate of a preterm delivery high risk group of pregnant women, using once daily natural progesterone agent.

NCT ID: NCT00335855 Withdrawn - Influenza Clinical Trials

Pharma-Pen (Formerly Innoject) Auto-injectory TIV

Start date: n/a
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained users to self-administer Influenza vaccines as compared to standard IM injections administered by a licensed healthcare professional (e.g. a nurse). Participants will be 120 healthy men and women aged 18 - 50 years who have not received influenza vaccine for at least four years and who have no experience in giving intramuscular or subcutaneous injections. Subjects will be randomly placed in one of three treatment types. They will receive one injection of commercially available Influenza vaccine and will be evaluated over the course of six months.

NCT ID: NCT00336154 Withdrawn - Clinical trials for Epidermolysis Bullosa

Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa

Start date: n/a
Phase: Phase 4
Study type: Interventional

Epidermolysis Bullosa(EB) is an inherited bullous disease. Tetracycline is believed to have anti inflammatory properties. 20 patients with EB older than 13 years will be treated for 4 months with tetracycline or placebo. After one month of wash out they will be treated for additional 4 m with placebo or tetracycline. The patients will be examined each month to estimate bulla formation,rate of healing .

NCT ID: NCT00338546 Withdrawn - Clinical trials for Cocaine Induced Sympathoexciation and Vasoconstriction

Study to Improve Scientific Understanding of the Cardiovascular Actions of Cocaine

Start date: n/a
Phase: Phase 1
Study type: Interventional

The purpose of this study is to improve the scientific understanding of the cardiovascular actions of cocaine, in particular the ability of cocaine to increase blood pressure.